首页LAURUSLABS • NSE
add
Laurus Labs Ltd
昨日收盘价
₹546.25
当日价格范围
₹541.55 - ₹555.00
年度波幅
₹360.85 - ₹555.00
市值
2858.36亿 INR
平均交易量
292.62万
市盈率
223.65
股息率
0.15%
主要交易所
NSE
市场资讯
财务信息
损益表
收入
净收入
(INR) | 2024年9月info | 年同比变化 |
---|---|---|
收入 | 122.37亿 | -0.06% |
经营支出 | 60.46亿 | 10.51% |
净收入 | 1.98亿 | -46.31% |
净利润率 | 1.62 | -46.36% |
每股收益 | 0.37 | -45.59% |
息税折旧摊销前利润 | 17.76亿 | -5.65% |
有效税率 | 20.33% | — |
资产负债表
总资产
负债总额
(INR) | 2024年9月info | 年同比变化 |
---|---|---|
现金及短期投资 | 4.49亿 | -33.11% |
总资产 | 872.93亿 | 8.34% |
负债总额 | 458.51亿 | 14.21% |
权益总额 | 414.42亿 | — |
发行在外的股份 | 5.36亿 | — |
市净率 | 7.09 | — |
资产回报率 | — | — |
资本回报率 | 2.60% | — |
现金流
现金净变动
(INR) | 2024年9月info | 年同比变化 |
---|---|---|
净收入 | 1.98亿 | -46.31% |
来自运营的现金 | — | — |
投资现金 | — | — |
融资现金 | — | — |
现金净变动 | — | — |
自由现金流 | — | — |
简介
Laurus Labs is an Indian multinational pharmaceutical and biotechnology company headquartered in Hyderabad. Its focus areas include active pharmaceutical ingredients, generic formulations, custom synthesis, biotechnology, veterinary APIs and agrochemicals. The company was founded in 2005 by Satyanarayana Chava.
Laurus Labs has its eight manufacturing plants located at Visakhapatnam, Hyderabad and Bangalore. The manufacturing units have received one or more approvals from USFDA, WHO, NIP Hungary, KFDA, MHRA, TGA, and PMDA. The company operates through its subsidiaries in Europe and United States and also offers its services in contract research, clinical research and analytical research through its R&D centers. The R&D centres are based in Hyderabad, Visakhapatnam and United States. Wikipedia
CEO
成立时间
2005
员工数量
6,007